The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFS.L Regulatory News (AFS)

  • There is currently no data for AFS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of EGM and Director Appointments

26 Mar 2021 07:00

RNS Number : 5650T
Amiad Water Systems Ltd
26 March 2021
 

26 March 2021

 

Amiad Water Systems Ltd.

("Amiad" or the "Company")

  

Notice of EGM and Director Appointments

 

Amiad (AIM: AFS), a leading global producer of water treatment and filtration solutions, announces the proposed appointment of Ms Ronit Fein and Ms Avital Refaely as statutory external directors of the Company.

 

The appointment of new statutory external directors and certain associated matters are required to be approved by a requisite majority of shareholders at an Extraordinary General Meeting ("EGM") of the Company. The EGM to approve the new directors' appointments, among other resolutions, is to be held at 9.00am BST on 6 May 2021 at the offices of Bryan Cave Leighton Paisner LLP, Governor's House, 5 Laurence Pountney Hill, London, EC4R 0BR.

 

In light of the current circumstances of the ongoing COVID-19 pandemic and government restrictions, the Board of Directors has arranged for the quorum of one shareholder present in person or by proxy holding, in aggregate, at least 25% of the voting rights in the Company to be physically present at the EGM and no other shareholders will be allowed to attend in person. To have their votes counted, all shareholders are urged to appoint the Chairman of the meeting as their proxy and holders of depository interests are urged to instruct Link Market Services Trustees to vote on their behalf.

 

Further information, including details on the EGM and the resolutions to be proposed at the EGM, can be found in the circular containing the Notice of EGM that, today, has been made available to shareholders of the Company as an electronic communication and published on Amiad's website at: https://amiad.com/list-circulars/ 

 

Proposed Director Appointments

 

Ms Ronit Fein, aged 49, has over 25 years' corporate and financial experience. She is currently CFO of Ahava Dead Sea Laboratories Ltd, an international cosmetics company that is based in Israel and with a global distribution network. Other positions have included Chief Economist at Keter Group, a manufacturer and marketer of resin-based household and garden consumer products that is valued at over $1bn. During her nine years at Keter Group, she was involved in M&A transactions and in developing business strategy, as well as in overseeing the turnaround of newly-acquired subsidiary companies. Ms Fein also served as a member of the Board of Directors of TASE-listed Hamat Group Ltd (formerly Merhav Ceramic and Building Materials Center Ltd).

 

Ms Avital Refaely (neé Treister), aged 51, has over 25 years' experience in business and marketing. She is currently VP Market Development, International Markets, for K Health, a primary care provider via a data-driven healthcare app, which in December 2020 raised $132m valuing the company at $1.5bn. Prior to joining K Health, she spent over 10 years as VP Marketing for the Ofer Malls of TASE-listed Melisron Group, a real estate development company and one of the largest operators of shopping centres in Israel. Other previous roles include CEO of Max Brenner, a chocolate restaurant and retail brand, where she oversaw the global expansion of the business, including the opening of its first location in the US in New York City.

 

Ms Fein and Ms Refaely will serve as statutory external directors of the Company, as required under Israeli Companies Law, for a three-year period commencing from the conclusion of the EGM.

 

 

Pursuant to Schedule 2(g) of the AIM Rules for Companies, Ronit Fein (aged 49) and Avital Refaely (aged 51) have held the following directorships or partnerships in the past five years:

 

Ms Ronit Fein

Current Directorships

Directorships within the last five years

N/A

N/A

 

 

Ms Avital Refaely

Current Directorships

Directorships within the last five years

N/A

British Israel Investments Ltd

 

Ronit Fein and Avital Refaely do not currently hold any shares in the Company.

 

There is no further information to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

 

Enquiries

 

Amiad Water Systems Ltd.

 

Dori Ivzori, Chief Executive Officer

Relly Shimko, Chief Financial Officer

+972 4 690 9500

 

Stifel Nicolaus Europe Ltd.

 

Fred Walsh, Stewart Wallace

+44 20 7710 7600

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

 

 

About Amiad

 

Amiad Water Systems (AIM: AFS) is a leading global producer of automatic, self-cleaning water treatment and filtration products and systems. Through its engineering skills and ability to innovate, Amiad provides cost-effective "green" solutions for irrigation and industrial purposes. In these markets, its unique and high-quality products are being integrated into the core of systems for filtration and water treatment, micro irrigation and membrane protection, wastewater and potable water treatment, cooling systems and sea water filtration. Headquartered in Israel, Amiad provides these solutions through ten subsidiaries and a comprehensive network of distributors to customers in more than 80 countries.

 

FIMI Opportunity Funds, the leading private equity investor in Israel, is a controlling shareholder of Amiad, with an interest in 39.5% of the Company's outstanding issued share capital.

 

For additional information or product details, please visit www.amiad.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUQPWUPGGBA
Date   Source Headline
28th Apr 200611:58 amRNSNotification of Interest
27th Apr 200611:19 amRNSNotification of Interests
24th Apr 20067:44 amRNSNotification of Interest
21st Apr 20062:46 pmRNSNotification of Interest
12th Apr 20069:34 amRNSNotification of Interest
12th Apr 20067:01 amRNSFinancial Reporting
11th Apr 20065:23 pmRNSDividend
31st Mar 200612:19 pmRNSNotification of Interest
29th Mar 20067:03 amRNSFull Year Results
21st Mar 20068:00 amRNSNotice of Results
2nd Mar 20063:26 pmRNSEGM Statement
6th Dec 20057:56 amRNSNine Months Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.